Psychemedics EPS - Earnings per Share 2010-2023 | PMD
Psychemedics eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Psychemedics Annual EPS |
| 2023 |
$-0.72 |
| 2022 |
$-0.19 |
| 2021 |
$-0.12 |
| 2020 |
$-0.70 |
| 2019 |
$0.28 |
| 2018 |
$0.83 |
| 2017 |
$1.10 |
| 2016 |
$1.22 |
| 2015 |
$0.28 |
| 2014 |
$0.60 |
| 2013 |
$0.72 |
| 2012 |
$0.57 |
| 2011 |
$0.67 |
| 2010 |
$0.50 |
| 2009 |
$0.29 |
| Psychemedics Quarterly EPS |
| 2023-12-31 |
$-0.16 |
| 2023-09-30 |
$-0.36 |
| 2023-06-30 |
$-0.13 |
| 2023-03-31 |
$-0.07 |
| 2022-12-31 |
$-0.12 |
| 2022-09-30 |
$-0.02 |
| 2022-06-30 |
$-0.06 |
| 2022-03-31 |
$0.01 |
| 2021-12-31 |
$-0.28 |
| 2021-09-30 |
$0.13 |
| 2021-06-30 |
$0.02 |
| 2021-03-31 |
$0.01 |
| 2020-12-31 |
$-0.10 |
| 2020-09-30 |
$-0.20 |
| 2020-06-30 |
$-0.37 |
| 2020-03-31 |
$-0.03 |
| 2019-12-31 |
$-0.09 |
| 2019-09-30 |
$0.12 |
| 2019-06-30 |
$0.14 |
| 2019-03-31 |
$0.11 |
| 2018-12-31 |
$0.16 |
| 2018-09-30 |
$0.23 |
| 2018-06-30 |
$0.21 |
| 2018-03-31 |
$0.23 |
| 2017-12-31 |
$0.42 |
| 2017-09-30 |
$0.25 |
| 2017-06-30 |
$0.16 |
| 2017-03-31 |
$0.27 |
| 2016-12-31 |
$0.43 |
| 2016-09-30 |
$0.49 |
| 2016-06-30 |
$0.30 |
| 2016-03-31 |
$0.00 |
| 2015-12-31 |
$0.03 |
| 2015-09-30 |
$0.15 |
| 2015-06-30 |
$0.05 |
| 2015-03-31 |
$0.05 |
| 2014-12-31 |
$0.13 |
| 2014-09-30 |
$0.17 |
| 2014-06-30 |
$0.16 |
| 2014-03-31 |
$0.14 |
| 2013-12-31 |
$0.16 |
| 2013-09-30 |
$0.20 |
| 2013-06-30 |
$0.20 |
| 2013-03-31 |
$0.16 |
| 2012-12-31 |
$0.05 |
| 2012-09-30 |
$0.17 |
| 2012-06-30 |
$0.19 |
| 2012-03-31 |
$0.16 |
| 2011-12-31 |
$0.09 |
| 2011-09-30 |
$0.21 |
| 2011-06-30 |
$0.21 |
| 2011-03-31 |
$0.16 |
| 2010-12-31 |
$0.07 |
| 2010-09-30 |
$0.16 |
| 2010-06-30 |
$0.17 |
| 2010-03-31 |
$0.10 |
| 2009-12-31 |
$0.10 |
| 2009-09-30 |
$0.15 |
| 2009-06-30 |
$0.03 |
| 2009-03-31 |
$0.01 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.015B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
